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ONE-POT SYNTHESES AND CHARACTERIZATIONS OF “CLICK-ABLE” POLYESTER POLYMERS FOR
POTENTIAL BIOMEDICAL APPLICATIONS

An Abstract of the Thesis by
James F. Beach II

In this study, a linear polyester polymer was designed using polyethylene glycol,
sorbitol, glutaric acid and 4-pentynoic acid as monomers. The synthesis was carried out using
standard melt polymerization technique and catalyzed by Novozyme-435, an enzyme suitable
for polymerization of biocompatible compounds. The progress of the reaction was monitored
with respect to time and negative pressure, with samples being subjected to standard
characterization protocols. Polymer with high molecular weight and water solubility were
chosen for further modification into folate-functionalized polymeric nanoparticles for targeted
drug delivery to cancer cells. This was achieved by employing a solvent diffusion method,
wherein the polymer can be simultaneously converted into water-soluble nanoparticles and
therapeutic agents (Taxol) and imaging dyes (DiI) can be encapsulated. The efficacy of this
delivery system was gauged by treating LNCaP and PC3 prostate cancer cells with the drug and
dye-loaded nanoparticles and assessing the results of the treatment. The results were analyzed
by cytotoxicity (MTT) assays, drug release studies, and confocal and fluorescence microscopy.
The experimental results collectively show a nanoparticle that was biocompatible, targetspecific, and successfully initiated apoptosis in an in-vitro prostate cancer cell model.
Keywords: Nanoparticle · Cancer · Polyester · Click chemistry · Nanomedicine

iv

TABLE OF CONTENTS
CHAPTER

PAGE

CHAPTER I: Introduction………………………………………………………………………………………………………….1-3
CHAPTER II: Literature Review…………………………………………………………………………………………………4-9
A History of Polymers………………………………………………………………………………………………….4-5
Biodegradable Polymers……………………………………………………………………………………………..5-6
Biomedical Applications of Polymers…………………………………………………………………………..6-7
Nanoparticles in the Role of Cancer Treatment…………………………………………………………..7-8
Cytotoxicity Assays……………………………………………………………….…………………………..………..8-9
CHAPTER III: Results and Discussion…………………………………………………………………………………….10-31
1. Polymer Synthesis and Characterizations
Polymer Synthesis………………………………………………………………………………………10-11
1
H NMR………………………………………………………………………………………………………11-14
13
C NMR……………………………………………………………………………………………………..14-16
FT-IR…………………………………………………………………………………………………………..16-18
MALDI-TOF………………………………………………………………………………………………...18-20
GPC…………………………………………………………………………………………………………….20-21
TGA…………………………………………………………………………………………………………….22-23
DSC…………………………………………………………………………………………………………….23-24
2. Polymeric Nanoparticle Synthesis and Characterizations
Nanoparticle Synthesis……………………………………………………………………………….24-25
DLS and Zeta Potential Determination………………………………………………………..25-28
Nanoparticle Absorbance and Fluorescence……………………………………………….28-29
3. Cell Culturing and Cytotoxicity Assays
MTT Assay………………………………………………………………………………………………….29-31
CHAPTER IV: Conclusions……………………………………………………..…….………………………..................32-33
CHAPTER V: Experimental Methods…………………………………………………………………….………………34-40
Materials……………………………………………………………………………………………………………………..34
Polyester Polymer Synthesis……………………………………………………………………………………34-35
Polymeric Nanoparticle Synthesis……………………………………………………………………………35-36
Folic Acid Conjugation……………………………………………………………………………………………..36-37
Instrumentation………………………………………………………………………………………………………37-39
Cell Studies……………………………………………………………………………………………………………..39-40

REFERENCES…………………………………………………………………………………………………………………………41-43

v

LIST OF FIGURES
FIGURE #

PAGE

1. The Reduction of MTT to Formazan………………………………………………………………………...9
2. Reaction Scheme for the Polymerization of a “Click-able” Polyester Polymer….…….11
3.

1

4.

1

5.

1

6.

13

7.

13

8.

13

H NMR Spectra of Starting Compounds………………………………………….…………………….12
H NMR Spectrum of PEG-300 Polyester Polymer………………………………………………….12
H NMR Spectrum of PEG-1000 Polyester Polymer………………………………………………..13
C NMR Spectra of Starting Compounds …………………..……………….………………..……….14
C NMR Spectrum of PEG-300 Polyester Polymer…………………………………………………15
C NMR Spectrum of PEG-1000 Polyester Polymer……………………………………………….15

9. FT-IR Spectra of Starting Compounds……………………………………………………………….…...16
10. FR-IR Spectrum of PEG-300 Polyester Polymer………………………………………………..…….17
11. FT-IR Spectrum of PEG-1000 Polyester Polymer…………………………………..………………..17
12. MALDI-TOF of PEG-300 Polyester Polymer…………………………………………………………….19
13. MALDI-TOF of PEG-1000 Polyester Polymer…………………………………………………………..19
14. GPC of PEG-300 Polyester Polymer………………………………………………………………………..20
15. GPC of PEG-1000 Polyester Polymer………………………………………………………………………20
16. TGA of PEG-300 Polyester Polymer………………………………………………………………………..21
17. TGA of PEG-1000 Polyester Polymer………………………………………………………………………22
18. DSC Curve of PEG-300 Polyester Polymer………………………………………………………………23
19. DSC Curve of PEG-1000 Polyester Polymer…………………………………………………………….23
20. Conversion of Polymer to Nanoparticles and Surface Ligand Modification…………….25
21. DLS of PEG-300 PNPs……………………………………………………………………………………………..26
22. DLS of PEG-1000 PNPs……………………………………………………………………………………………26
23. Average Surface Zeta Potential of PEG-300 PNPs…………………………………………………..27
24. Average Surface Zeta Potential of PEG-1000 PNPs…………………………………………………27
25. Absorbance of PNPs with Encapsulated DiI Dye………………………………………………..…..28
26. Fluorescence Emission of PNPs with Encapsulated DiI Dye …………………………..………29
27. Cytotoxicity Effects of PNPs on LNCaP Prostate Cancer Cells………………………………...30
28. Cytotoxicity Effects of PNPs on PC3 Prostate Cancer Cells……………………………..........31
29. Synthesis of Azide-Functionalized Folic Acid………………………………………………………….36

vi

CHAPTER I

INTRODUCTION

To the average person, the world “polymer” brings only a few things to mind. It likely
invokes images of conventional, mundane objects: desks, chairs, bottles, and the like. However,
the meaning and impact within this word goes much deeper than household items and
manufacturing materials. The field of polymer science has affected the way of life (for better
and worse) for most life forms on this planet for the greater part of the last century. This trend
is likely to continue, as the demand for polymer-based solutions to many of the world’s material
problems increases. This demand compels polymer science to permeate into disciplines that
have never been thought possible. Fortunately, this cross-over has become a reality with the
technological and intellectual strides that have been made in modern times.
One such area polymer science has invaded is the field of biomedicine and
nanotechnology. Conventional treatments for the world’s more worrisome diseases have
become somewhat dated and are occasionally detrimental to the overall well-being of the
patient. Current cancer treatment methods often leave a patient in a more compromised state
of health than the cancer alone. Chemotherapeutics and radiation therapy occasionally fail to
impede the disease’s progress while simultaneously subjecting the patient to undesirable side
effects (hair loss, nausea, loss of appetite, etc.). Fortunately, polymer science has risen to
answer the call for new treatment methods in the unorthodox form of polymeric nanoparticles.
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Polymeric nanoparticles (PNPs) are a relatively new development in the field of
medicine, and polymer science in general. Biologically compatible polymers (typically dendritic
polymers) can be synthesized using commercially available chemicals to create new compounds
with biomedical applications. However, there are many caveats to creating a suitable polymer
for medicinal applications. These compounds must be innately non-toxic to the host upon
administration, as well as degrade and pass through the body without complication. The
polymers must also be able to overcome any innate hydrophobicity to be converted onto a
nanoparticle solution. The resulting particles must then exhibit enough stability to be deemed
appropriate for the encapsulation of therapeutics and optical dyes.
The subject of this thesis focuses on the synthesis of one such polymer, utilizing
polyethylene glycol as the primary bulk of the polymeric backbone to improve the hydrophilicity
of the polymer, as water solubility is necessary in polymers that may see implementation in
biological systems. The other monomers used were glutaric acid, sorbitol, and 4-pentynoic acid.
Glutaric acid and sorbitol were chosen for their already well-established biocompatibility in-vivo,
the former being a natural byproduct of various metabolic processes, and the latter being the
reduced form of d-glucose.1,2 The 4-pentynoic acid was chosen to ensure an alkyne (C≡C) surface
functionality when converted to polymeric nanoparticles. This allows for the polymeric
nanoparticles to be immediately modified via “click” chemistry, wherein azide-terminated folic
acid can be reacted with these surface groups to serve as selective ligands.
Following synthesis and modification of the polymeric nanoparticle solution, the
anticancer drug Paclitaxel (Taxol) and DiI optical dye was encapsulated within the polymer for
this drug delivery system. These polymeric nanoparticles were incubated with LNCaP and PC3
prostate cancer cells to analyze the results of treatment via cytotoxicity assay. LNCaP prostate
cancer cells express a prostate-specific membrane antigen (PSMA) that displays high affinity for
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folic acid, which is lacking in PC3 cells. From this, it can be gauged whether the proposed system
can selectively treat cancers expressing this receptor, or if this formulation needs revising as the
project moves toward in-vivo studies.
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CHAPTER II

LITERATURE REVIEW

A History of Polymers
A polymer can be defined as a large macromolecule consisting of a massive number of
repeat units called monomers.3,4 Polymers have a ubiquitous presence in the lives of all
organisms on our planet, whether they occur naturally (DNA, lignin) or are created synthetically
(plastics, nylons). The first strides into the field of polymer science were made by German
chemist Hermann Staudinger, who documented the existence of these macromolecules in
1920.5 Staudinger’s work with rubbers led him to believe there may be something more
contributing to the large molecular weights that he was obtaining experimentally. He was
convinced that rubber and other large molecular weight compounds (cellulose, proteins, etc.)
were comprised of long chains of repeating units with covalent linkage.6,7 He proposed these
thoughts and findings in his landmark 1920 paper, which was met with widespread criticism
from his contemporaries.
At the time, the widely-held belief was that unusually high molecular weights (above
5,000 g/mol) were due to the aggregation of molecules into a colloidal structure, and that
covalent linkage between two identical molecules was impossible.6 It wasn’t until the late 1930s
that Staudinger could further validate his claims into scientific proof, with the help of some likeminded scientists. Austrian-American chemist Herman Mark was able to support Staudinger’s
macromolecular theory with his work on the x-ray diffraction of fibers, which provided
4

significant evidence for existence of numerous covalent linkages within a sample.8 The American
chemist Wallace Carothers, who had long been a pioneer in organic chemical synthesis,
contributed strongly to the Staudinger’s claims with his discoveries of polyesters and nylon
(polyamides).9 The work of these scientists helped propel Staudinger’s theory into a solid
foundation for polymer science, and allowed the discipline to develop into the widespread and
economically important industrial and research fields that exist today.

Biodegradable Polymers
The synthesis of biodegradable polymers hearkens back to the late 1980s, when nonindustrial applications of polymers were first being explored.10,11 The earliest conducted research
saw scientists attempting to integrate natural polymer derivatives (polysaccharides, lipids, etc.)
into the fields of agriculture, medicine, and ecology.10-12 The aim was to create polymers with
readily hydrolysable backbones, which would degrade naturally within various environments
(physiological pH, nitrogen in soil) in order to facilitate exogenous processes (nitrogenation, soil
stabilization).10 However, it was found that natural polymers were not very susceptible to
degradation, making their potential for use in biological and other natural fields limited. This has
compelled researchers to design and synthesize new polymers, using monomer compounds
that, at the time, were quite unconventional. Compounds like sugar derivatives, amino acids,
and alcohols were used to synthesize polymers that were not only biodegradable, but
biocompatible in certain cases.12
In particular, synthetic polyester biopolymers came to prominence in this field due to
their ease of synthesis, high molecular weight, biocompatibility and degradation.10,12 Initial
research in this synthesis saw wide usage of polylactic acid (PLA) as the standard for
biocompatible and biodegradable polyester synthesis.13 PLA is derivative of lactic acid, a
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compound produced naturally in all animals as a byproduct of various metabolic processes
(Krebs and Cori cycles, gluconeogenesis).14 As such, this greatly increases the odds of PLA-based
polymers being successful when introduced into a biological system. Naturally, the synthesis of
biocompatible polyesters has become more intricate, using dicarboxylic acids and diols as
monomers to make completely original compounds. Ventures into custom-made biopolymers
have seen their greatest results in hyperbranched and dendrimer synthesis, unique polymers
that have demonstrated remarkable potential in the field of medicine and biological sciences.15

Biomedical Applications of Polymers
In the field of medicine, polymers have seen success as vehicles for site-specific drug
delivery, biosensors, and gene therapy.16-18 They perform this role by being converted into
polymeric nanoparticle solution, bestowing them with new and enhanced properties.
Nanoparticles are particles of 1-1000 nm diameter into which dendritic and certain linear
polymers can be converted when dispersed in the appropriate solvent. Once dispersed, these
molecules orient themselves into nano-sized geometric shapes (spheres, rods, globular),
wherein the polymer backbone comprises the inner matrix and certain functional groups (polar)
are on the outer surface of the particle.16,19 This is controlled in the initial synthesis of the
monomer, where the compound containing the desired surface functionality is kept in molar
deficiency or excess, depending on the synthetic method and type of polymer (e.g. linear
polymers will form a matrix via crosslinking), to the other reactants.16,19 Additionally, the chosen
surface functionality is often a polar compound (primary amines, alcohols) due to their
hydrophilicity, which make them available for further modification.16,19
The creation of the polymer matrix of the nanoparticle creates a network of pockets,
not unlike a spider web, that possess unique properties. This intramolecular space is created
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due to electrostatic repulsion (e.g. carbonyl oxygens) or pendant groups present in the
polymeric backbone, as well as the innate hydrophobicity of the aliphatic backbone.19,20 In the
case of linear polymers, this intramolecular space is generated in some part due to light
crosslinking between adjacent molecules. This internal space can be utilized for the
encapsulation of various small molecules, typically hydrophobic drugs and optical dyes, within
the nanoparticle. The nanoparticles act as a freighter, protecting its cargo from outside
interference and preserving their activity en route to a cell or tumor.16-20 This feature is of
significant interest in medical research, and is changing the way researchers approach disease
treatment.

Nanoparticles and Their Role in Cancer Treatment
The ability of nanoparticles to encapsulate small molecules has seen them rising to
prominence in the discovery of new disease treatment methods, particularly for cancer.17-20 In
this regard, nanoparticles display great potential to move away from systemic treatment and
towards targeted drug delivery. This is accomplished by encapsulating drugs and other
compounds (dyes, MRI contrast agents) within the nanoparticle, which are released upon
cellular uptake. The uptake is facilitated by receptor-mediated invagination of the nanoparticle,
after which the polymer matrix is degraded by the abnormally low pH (approx. 4-5) of the tumor
cytosol.18-20 This releases the cargo molecules directly into the cell, simultaneously administering
the drug and allowing for monitoring of the cell’s size as apoptosis occurs.16-20 This gives the
nanoparticle the multimodality of both a therapeutic and diagnostic agent, something seldom
seen in the realm of conventional cancer treatment.
Nanoparticles can be further modified by bonding ligands to their surface functional
groups, which allow for specific receptor targeting. This ensures that the encapsulated
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compounds only enter cells of interest. This is often a necessary modification, as many of the
default surface functionalities (carboxylates and hydroxyls) would display electrostatic repulsion
with the overall negative charge of the cell membrane.16-20 This allows the nanoparticle to act as
a Trojan horse, deceiving the tumor into absorbing its toxic payload. In many cancers, there is an
overexpression of folic acid (folate) receptors in the outer membrane, which is lacking in healthy
cells.21 As the name implies, these receptors show a high affinity for folic acid, which can be
used against the tumor cell while leaving neighboring healthy tissues unaffected.21
Nanoparticles can be decorated with targeting ligands by reacting the surface functional group
of unmodified nanoparticles with a functional group of the desired (and usually modified) ligand
molecule.16-20 This conjugation is usually accomplished via carbodiimide (CDI) cross-linker
(amine, hydroxyl, or carboxyl decorated nanoparticles) or “click” (alkyne decorated
nanoparticles) chemistries and their respective counterpart functionalities on the ligand.22-23

Cytotoxicity Assays
Successful conjugation of the nanoparticles and their targeting molecule are confirmed
by various biological assays, in which the nanoparticles are incubated with cancer cells.16-20
These assays are performed to confirm the selectivity of the nanoparticles, as there should be
no display of cytotoxicity in the control cells that lack folate receptors. One such test is the MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cytotoxicity assay. This assay
calculates the degree of cytotoxicity by utilizing MTT as a colorimetric indicator. MTT is a yellow
tetrazole compound which, when catalyzed by mitochondrial reductase, undergoes reduction to
formazan, a violet crystalline compound (Figure 1).24

8

Figure 1: The Reduction of MTT to Formazan

Mitochondrial reductase is a NAD(P)H-dependent oxidoreductase produced during
typical cellular metabolism.25 As such, the amount of this enzyme produced in a cell is
dependent on its overall health, as can be qualitatively determined by its ability to reduce
MTT.24-25 Cells undergoing apoptosis will produce much lower levels of mitochondrial reductase
and, subsequently, lower levels of formazan. The degree of cytotoxicity can be determined
quantitatively by analyzing the absorbance spectra (at 500-600 nm) of the cells with respect to
formazan production.24-25

9

CHAPTER III

RESULTS AND DISCUSSION

1. Polymer Synthesis and Characterizations
Synthesis: The polymer was synthesized using compounds known to individually exhibit
high levels of biocompatibility and hydrophilicity. Additionally, one of the reagents (4-pentynoic
acid) was chosen to create surface functionalities amenable to “click” chemistry once the
polymer is converted to a nanoparticle suspension.19-20 For the synthesis of the polymer, melt
polymerization with an enzyme catalyst (Novozyme-435) was utilized. The selected reagents
were sorbitol, glutaric acid, 1000 MW polyethylene glycol (PEG-1000) and 4-pentynoic acid in a
molar ratio of 1: 2: 1: 0.5, respectively. This was done to ensure equimolarity of the polyols
while providing the glutaric acid in excess, which would increase the odds of esterification
occurring between these three compounds. The 4-pentynoic acid was provided in molar deficit
to reduce the chances of it reacting with primary hydroxyl groups, as that would terminate
polymerization on one end of the growing chain. A separate reaction utilizing 300 MW
polyethylene glycol (PEG-300) was also performed, maintaining the same molar equivalents as
the first. A proposed scheme of the reaction and resulting polyester polymer is shown in Figure
2. Samples of each polymer that had undergone 48 hours of reaction were subjected to
standard chemical and polymeric characterizations, as detailed in the following sections.

10

1

H NMR: The proton NMR spectra for each of the starting compounds and polymer

samples are shown in Figures 3-5. The TMS reference peak was observed at 0 ppm. The solvent
peak for DMSO-d6 was observed as a singlet around 2.5 ppm in each of the spectra, except in the
4-pentynoic acid spectrum, which was performed in chloroform-d (7.25 ppm).
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Figure 3: 1H NMR Spectra of Starting Compounds

Figure 4: 1H NMR Spectrum of PEG-300 Polyester Polymer

12

Figure 5: 1H NMR Spectrum of PEG-1000 Polyester Polymer

The peak at 3.50 ppm representing the protons in both PEG-300 and PEG-1000 were
seen in the spectra for both polymers. This peak inserted itself between the peak clusters of the
aliphatic (3.3-3.7 ppm) and hydroxyl (4.1-4.5 ppm) protons found in sorbitol. The methylene
protons of glutaric acid and 4-pentynoic acid were observed at 1.74 ppm and 2.34 ppm. The
alkyne peak of 4-pentynoic acid was observed at around 2.23 ppm in the polymer spectra.
The spectra of the polymers showed the major functionalities of the monomer
compounds present within their overall structure. Polymers, due to their large molecular
weights and the presence of multiple protons in the same environments within the repeat units,
tend to manifest as much broader and irregular peaks compared to those seen in non-polymeric
compounds. This can cause overlapping or masking of some of the weaker signals in the spectra,
which makes them more difficult to isolate and analyze. Generally, the positions of distinct
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peaks from the monomer compounds are used as a marker for location in the polymer’s spectra,
as they should appear in a similar region.
It is also worth noting that in the spectra for 4-pentynoic acid and glutaric acid, the
characteristic peak for the carboxyl hydrogen (around 10-12 ppm) was not observed. This likely
is due to the hygroscopic nature of the deuterated solvents, as they are can absorb moisture if
precautionary measures are not taken during preparation of the samples and transfer to the
NMR tube. The acidity of these protons means that they are exchangeable with those of the
water contaminant, which may cause the carboxylic acid proton peak to diminish or disappear.27
This is supported by the presence of the very shallow and broad band at 3.40 ppm in the glutaric
acid spectra, which is indicative of water in the sample.
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C NMR: The carbon-13 NMR spectra for the monomer and polymer samples are shown

in Figures 6-8. The solvent peak for DMSO-d6 manifests as a strong multiplet at 40 ppm in each
of the spectra.

Figure 6: 13C NMR Spectra of Starting Compounds
14

Figure 7: 13C NMR Spectrum of PEG-300 Polyester Polymer
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Figure 8: 13C NMR Spectrum of PEG-1000 Polyester Polymer
The peaks of the carbonyl carbons in both acid monomers were observed at 173 ppm.
The peak around 70 ppm was indicative of the carbons of both PEG compounds. The peak at
68.7 ppm represented the terminal alkyne carbon of the 4-pentynoic acid. The peaks around 61
and 64 ppm represented the aliphatic carbons of sorbitol. The peak around 33 ppm represented
the carbon adjacent to the carbonyl groups in both glutaric acid and 4-pentynoic acid. Finally,
the carbon adjacent to the alkyne bond in 4-pentynoic acid was observed around 14 ppm. As
with the proton NMR, the relative shifts of the peaks in the individual compounds were used as
a landmark to locate similar peaks in the spectra of the polymer.

FT-IR: The FT-IR spectra for the monomer compounds is shown in Figure 9, while spectra
for the PEG-300 and PEG-1000 polyester polymers can be seen in Figures 10 and 11,
respectively.

Figure 9: FT-IR Spectra of Starting Compounds
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Figure 10: FT-IR Spectrum of PEG-300 Polyester Polymer

Figure 11: FT-IR Spectrum of PEG-1000 Polyester Polymer
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As observed in the FT-IR spectra, the distinctive strong peak at around 1735 cm-1
represented the ester carbonyl (C=0) bond, suggesting successful polymerization of the
monomer compounds. This was further confirmed by the strong peak at 1130 cm-1, indicating CO stretching from both the ester and aliphatic ether linkages (from PEG). The strong peak at
2880 cm-1 represented the alkyl (C-H) bond stretching, as was expected in aliphatic polymers.
The broad, shallow stretching from 3340-3650 cm-1 was indicative of the hydroxyl (O-H) groups
of the sorbitol. Faint alkyne stretches were observed near 2200 cm-1 (CΞC) and 3265 cm-1 (C-H).
These peaks lacked the distinct sharpness of standard terminal alkynes, but this weakness was
attributed to the molar deficit (around 25% molar deficit, as compared to the highest molar
equivalent reagent) to which the 4-pentynoic acid was used in the synthesis, and may be
masked by the frequencies of other nearby bond stretches.

MALDI-TOF: The results of MALDI-TOF scanning can be seen below in Figures 12 and 13.
The polymers were cast in a matrix comprised of TA30 solution and 2,5-dihydroxybenzoic acid
and analyzed using Bruker’s “flexcontrol” MALDI imaging software.
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Figure 12: MALDI-TOF of PEG-300 Polyester Polymer

Figure 13: MALDI-TOF of PEG-1000 Polyester Polymer
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Large fragments with Mn values of 34,100 and 43,670 were observed for the PEG-300
and PEG-1000 polymer samples, respectively. To calculate the potential Mw, the polydispersity
index (PDI) of 1.8 obtained from GPC was used, which is typical of synthetic polyester
polymers.28 Using this PDI value and the corresponding equation (PDI= Mw/Mn), a Mw of
61,380 and 88,740 was obtained for the PEG-300 and PEG-1000 polymer samples, respectively.
Both the PEG-300 and PEG-1000 polyester polymers showed polymers with high molecular
weight. This exceeded the literature values of polyester polymers synthesized in a similar
manner, but it was suspected it would have no detrimental effects to its function due to its
water solubility.

GPC: The results of gel permeation chromatography of each polymer samples can be
seen in Figures 14 and 15.

Figure 14: GPC of PEG-300 Polyester Polymer
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Figure 15: GPC of PEG-1000 Polyester Polymer

As seen in the spectra, both samples displayed elution of high molecular weight product
at around 32 minutes and 28 minutes for the PEG-300 and PEG-1000 polymers, respectively.
This suggested that the PEG-1000 polymer was higher in molecular weight when subjected to
equal reaction time (also confirmed by MALDI). This was also supported by the presence of
additional peaks in the PEG-300 spectra, which appear between 35-37 minutes of elution time.
This may be indicative of smaller weight fractions or oligomers present in the sample. It also was
determined that each sample had a PDI around 1.8.

TGA: The results of thermogravimetric analysis for the two samples are shown in Figures
16 and 17.
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Figure 16: TGA of PEG-300 Polyester polymer

Figure 17: TGA of PEG-1000 Polyester Polymer

Both polymer samples exhibited degradation (10% weight loss) at temperatures around
370°C. This degradation temperature was slightly higher than is typical of polyesters, which tend
22

to degrade around 350°C. This could be attributed to light cross-linking occurring between the
carboxyl groups in the pendants and the hydroxyl groups in the sorbitol component, which
would increase degradation temperatures. Regardless, the TGA results suggest that the polymer
will easily remain thermostable at biological temperatures (37°C) and with no threat of thermal
degradation.

DSC: The results of differential scanning calorimetry for the polymer samples are shown
in Figures 18 and 19.

Figure 18: DSC Curve of PEG-300 Polyester Polymer
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Figure 19: DSC Curve of PEG-1000 Polyester Polymer

Both polymer samples displayed glass transition temperatures (Tg) at approximately
-50°C, crystallization temperatures (Tc) around -29°C, and melting temperatures (Tm) around
31°C. This showed characteristics of a polymer possessing low degrees of crystallinity (or
somewhat amorphous). The low Tg and Tc are likely due to the presence of PEG in each of the
polymers, as the large number of ether linkages in the polymer backbone confers chain
flexibility.26

2. Polymeric Nanoparticle Synthesis and Characterization
Following characterization, the polymers were converted into polymeric nanoparticles
(PNPs) for drug and dye encapsulation utilizing a “solvent diffusion” method. This method
utilizes rigorous mixing to force the polymer and the hydrophobic cargo to interact, encouraging
the dye molecules to be encapsulated within the hydrophobic pockets of the polymer matrix.
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Characterizations for these nanoparticles are included in the following sections, and a scheme
detailing the full nanoparticle synthesis and modification can be seen in Figure 20.

Figure 20: Conversion of Polymer to Nanoparticles and Surface Ligand Modification
DLS and Zeta Potential Determination: Following cargo encapsulation, folate
modification and dialysis, the nanoparticles were subjected to Dynamic light scattering (for
diameter determination) and surface charge (zeta potential) determination. Zeta potential
determination is a technique somewhat exclusive to nanotechnology, which measures the
potential difference between the surface of a particle immersed in a conducting liquid and the
bulk of the liquid. This is important to gauge, as it allows one to monitor the success of surface
modification via changes in the overall surface charge of the nanoparticles. Since cell
membranes possess a negative charge, it is important to produce nanoparticles with either
overall positive surface charge or receptor-specific ligands. The results of both analyses are
shown in Figures 21-24.
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Figure 21: DLS of PEG-300 PNPs

Figure 22: DLS of PEG-300 PNPs
The analysis showed two types of PEG-300 polymeric nanoparticles, with diameters
49.90 nm to 240.0 nm, comprising 10.7% and 89.3% of the sample, respectively. The PEG-1000
polymeric nanoparticles displayed particles with 19.43 nm and 233.7 nm diameters, comprising
17.7% and 82.3% of the sample, respectively. It is likely that the larger particles were
agglomerates of multiple nanoparticles, which may occur as the samples remain undisturbed for
long periods (around 3-7 days).29 Despite this, these sizes are within acceptable ranges for usage
in targeted drug delivery in-vitro, since nanoparticles exceeding 500 nm in diameter suffer from
issues with receptor binding and cellular uptake.19-20
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Figure 23: Average Surface Zeta Potential of PEG-300 PNPs

Figure 24: Average Surface Zeta Potential of PEG-1000 PNPs

The results of the surface zeta potential show average vales of -18.7 mV and -19.8 mV
for the PEG-300 and PEG-1000 polymeric nanoparticles, respectively. These values were
expected, as the carbonyl oxygens present in the 4-pentynoic acid surface pendants and the
secondary alcohols in the sorbitol component of the polymer would result in an overall negative
charge. These relatively low charge values may also play a part in the larger diameters seen in
both samples, as the attractive forces may exceed repulsive ones.29-30 These values matter little
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in the nanoparticle’s ability to be taken up by the cells, however, as they will eventually be
modified for folate receptor targeting, which supersedes the surface charge of the molecules.
Nanoparticle Absorbance and Fluorescence: Following encapsulation of DiI and surface
decoration with folic acid, the nanoparticles were analyzed by absorbance and fluorescence
spectroscopy. This was performed to determine the presence of DiI dye and folic acid after the
completion of synthesis and dialysis, as well as to determine if they maintained their activities
after encapsulation. The results of these analyses are shown in Figures 25 and 26.
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Figure 25: Absorbance of PNPs with Encapsulated DiI Dye
The absorbance spectra for the PNPs showed absorbance at 350 nm and in the 520-560
nm range, indicative of folic acid and DiI, respectively. This indicated that the cargo molecules
were present within the nanoparticles and the folic acid ligands conjugated to the surface
maintained their absorbance through the synthesis and purification. The somewhat broadened
absorbance for DiI was likely due to the polymer matrix and the media (deionized water) in
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which the nanoparticles were suspended, which can cause absorbance to deviate slightly from
the expected values.
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Figure 26: Fluorescence Emission of PNPs with Encapsulated DiI Dye
The fluorescence emission spectra showed the characteristic peak for DiI in the range of
650 to 700 nm. As mentioned before, the broadening of the peak beyond this range was
attributed to the deionized water in which the nanoparticles were dispersed. Regardless, the
results showed that the dye maintains its fluorescence activity within the nanoparticle. This
would suggest that this nanoparticle system would be suitable for fluorescence imaging that
would show real-time progress of the effects of therapeutics on the treated cells.
3. Cell Culturing and Cytotoxicity Assay
MTT Assay: To determine the efficiency of the nanoparticle’s cellular uptake and
cytotoxicity, the cells were subjected to an MTT assay. LNCaP and PC3 prostate cancer cells
were cultured in a 96-well plate and incubated with 50 µL each of (1) PNP-DiI and (2) PNP-DiI-Fol
and (3) PNP-DiI-Fol-Tax from both nanoparticle samples. A well for untreated (control) cells
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were also cultivated for comparative purposes. The nanoparticles were permitted 24 hours of
incubation (with results assessed at 6, 12 and 24 hours) within a humidified incubator at 37°C
and 5% CO2 atmosphere. After the incubation, the cells were treated with the MTT/ Phosphatebuffered saline (PBS) solution and incubated for an additional 4-6 hours. The apoptotic effects of
the treatment are measured with respect to the absorbance intensities of the MTT compound
(560 nm). The cumulative results of these experiments are detailed in Figure 27 and 28.
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Figure 27: Cytotoxicity Effects of PNPs on LNCaP Prostate Cancer Cells
Figure 27 revealed that the folate-functionalized nanoparticles carrying Taxol displayed
significant cytotoxicity to LNCaP cells, killing approximately 50% of the cells after only 12 hours
of incubation. Those subjected to 24 hours of incubation displayed approximately 80% cell
death. Conversely, nanoparticles lacking the encapsulated Taxol did not display reduction in cell
viability. This suggested that our functionalized nanoparticles encapsulating anticancer drugs
entered these cells and degraded, releasing Taxol to the cytosol and initiated apoptosis.
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MTT Assay of PC3 Cells
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Figure 28: Cytotoxicity Effects of PNPs on PC3 Prostate Cancer Cells
This assay was also performed on PC3 prostate cancer cells to gauge the selectivity of
our functionalized nanoparticles, as these cells lack the PSMA receptor. As seen in the results for
the PC3 MTT assay, no significant cell death was observed in any of the trails. This was due to
PC3 cells’ lack of the PSMA receptor expressed in the LNCaP cell line, which displays a high
affinity for folic acid. This provided evidence that our functionalized nanoparticles were selective
for cell lines expressing the PSMA receptor, as significant cytotoxicity was only observed in the
LNCaP cells. The slight reduction in PC3 cell viability observed at longer incubation times was
attributed to disruption of the media (e.g. slight changes in pH) as exposure to nanoparticles
increased.
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CHAPTER IV

CONCLUSION

A synthetic, hydrophilic polyester polymer was synthesized using biocompatible
monomers. The various characterizations of the polymer showed a compound with high
molecular weight, thermostability, and alkyne surface functionality that permitted further
modification as a drug delivery system. The polymer was successfully converted into a polymeric
nanoparticle suspension, possessing nano-scale diameters and alkyne surface functionalities
that were further modified by “click” chemistry. The nanoparticles also successfully
encapsulated the optical dye and anti-cancer drug while remaining stable at physiological
conditions. Cytotoxicity assays showed the nanoparticle’s efficacy and specificity for LNCaP
prostate cancer, killing around 80% of these cells after 24 hours of incubation.
Looking forward, fluorescent microscopy on the cells following treatment need to be
conducted, as this presents another means to track the progression of therapy. Microscopy is
more applicable to the biological and medical aspects of this project, but also makes the results
of therapy observable for more qualitative analysis. Release studies also need to be performed
on the polymeric nanoparticles, dialyzing them in the presence of esterase and varying pH
levels. This would aid in determining the amount of cargo molecules released into the cells over
time, as well as elucidating other types of conditions the nanoparticles can endure. Finally,
modification of the protocol for use in in-vivo mice models expressing prostate cancer needs to
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be considered. This would entail synthesizing nanoparticles with even smaller diameters (below
10 nm), as the sizes obtained in this project may be incompatible in living models. Observation
of the qualities of the polymers created from lower reaction times (24 hours or less) to
determine if they could provide particles of smaller diameters is also a topic of interest.
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CHAPTER V

EXPERIMENTAL METHODS

Materials
The near-infrared fluorescent dye 1,1'-Dioctadecyl-3,3,3',3'tetramethylindocarbocyanine perchlorate (DiI) and the chemotherapeutic drug Paclitaxel (Taxol)
were purchased from Invitrogen and ThermoFisher, respectively. Deuterated dimethyl sulfoxide
(DMSO-d6) and chloroform (CDCl3) for use in 1H NMR and 13C NMR spectroscopy were purchased
from Sigma-Aldrich. The various solvents used for solubility determination (methanol, dimethyl
sulfoxide, tetrahydrofuran, and toluene) of the polymers were purchased from Sigma-Aldrich or
Acros Organics and used as received. Sorbitol, glutaric acid, PEG-1000, and 4-pentynoic acid
were purchased from Sigma Aldrich and used without further purification. 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and 4' 6-diamidino-2phenylindole (DAPI) were purchased from Biotium. LNCaP and PC3 prostate cancer cells were
obtained from the American Type Culture Collection (ATCC) organization and cultured per their
supplied protocol.

Polyester Polymer Synthesis
Sorbitol (1.38 g, 7.57 mmol), glutaric acid (2.0 g, 15.14 mmol), 4-pentynoic acid (0.371g,
3.78 mmol) and either polyethylene glycol 1000 (7.57 g, 7.57 mmol) or polyethylene 300 (2.27 g,
7.57 mmol) were added to a 50 mL round-bottom flask containing a stir bar, then placed in an
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oil bath heated to 110°C until all the compounds had melted. After melting, the temperature
was reduced to 95°C and Novozyme-435 (400 mg), a lipase catalyst used for esterification at
lower temperatures below 100°C, was added to the melt. The flask was topped with a vacuum
adapter, attached to a Schlenk line, and flushed with nitrogen gas (99.99% purity) to create an
inert atmosphere. The reaction proceeded for 12 hours under nitrogen atmosphere, after which
the mixture was treated with a high vacuum (4x10-4 mm/Hg). The vacuum exposure (applied to
remove the water byproduct and drive the reaction to completion) lasted 72 hours, with two 2-3
g samples taken at 48 and 72 hours of total reaction time.
To purify the polymer, each sample was dissolved in methanol and filtered through P8grade (fine) filter paper to isolate the polymer solution from the expended catalyst. The isolated
sample was placed in 50 mL round-bottom flask and subjected to rotary evaporation (low
vacuum and 60°C) to remove the methanol. If necessary, the samples were subjected to direct
high vacuum to further ensure the complete removal of methanol. The purified PEG-300
polyester polymer possessed a molasses-like texture and viscosity, while the PEG-1000 polyester
polymer was more wax-like. Both the 48 and 72 hr. samples of the PEG-300 and PEG-1000
polymers were found to be soluble in water, dimethyl sulfoxide (DMSO), chloroform (CHCl3),
dimethyl formamide (DMF) and tetrahydrofuran (THF).

Polymeric Nanoparticle Synthesis
The polymer (30 mg) was placed in an Eppendorf tube and dissolved in DMSO (250 μL).
Then DiI optical dye (2 μL) and Taxol (2 μL) were added to the polymer solution and vortexed for
approximately 3 minutes at 1500 rpm. The resulting mixture was slowly added dropwise (8 μL
aliquots) to a 15-mL centrifuge tube containing deionized water (4 mL) with continuous
vortexing. Once the polymer-cargo mixture has been completely added to the water, the
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centrifuge tube was capped and the vortex speed increased to 2500 rpm. The drug and dyeencapsulating nanoparticle exhibited a faint pink color (indicative of encapsulated DiI) and was
devoid of precipitate. The mixture was then transferred to a porous dialysis sleeve (MWCO= 3-6
kDa) for dialytic purification in deionized water for 1 hour.

Folic Acid Conjugation
Further modification of the surface functional groups was necessary for selective
treatment of LNCaP prostate cancer cells. Due to the presence of C≡C surface functional groups,
the nanoparticles were amenable to “click” chemistry with azide-functionalized folic acid (FolN3). The addition of the folate ligand allows for selective uptake by LNCaP cells, which are
known to overexpress folate receptors at the cell membrane exterior. The synthesis and
preparation for Fol-N3 is detailed in the following section and in Figure 29.

Figure 29: Synthesis of Azide-Functionalized Folic Acid
Modification of the folic acid begins with the synthesis of aminopropyl azide. This is
accomplished by adding 3-bromopropyl amine (7 g, 0.051 mol) and of sodium azide (14.23 g,
0.219 mol) to a 100 mL roundbottom flask containing deionized water (40 mL), which is then
heated to 80°C for 20 hours. Thereafter, solvent was removed in a rotary evaporator under low
vacuum, followed by the addition of potassium hydroxide (2 g, 0.036 mol) and extraction with
petroleum ether.
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For the next sequence in the synthesis, folic acid (0.05 g, 0.113 mmol) was dissolved in
DMSO (2 mL). In a separate vial, of 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) (0.02
g, 0.129 mmol) and N-Hydroxysuccinimide (NHS) (0.013 g, 0.113 mmol) were combined in 2-(Nmorpholino) ethanesulfonic acid (MES) Buffer (0.5 mL, pH 5.0). Both solutions were combined
and allowed to incubate at room temperature for 3 minutes. Following the brief incubation,
aminopropyl azide (0.007 g, 0.07 mmol) was dissolved in PBS (0.025 mL), added dropwise to the
mixture, and incubated for an additional 3 hours. Lastly, the solution was centrifuged at 5000
RPM and the azide-functionalized folic acid supernatant collected and dissolved in DMF (1 mL)
until further use.
To complete the bonding to the nanoparticles, nanoparticle suspension (2 mL) in a
bicarbonate buffer (pH=7.4) was combined with the azide-functionalized folic acid dissolved in
DMF (0.02 mol). Copper iodide (0.001 mmol) in DMF (5 µL) was added to the mixture and
incubated at room temperature for 12 hours on a table mixer, after which the reaction mixture
was purified by dialysis in deionized water, and stored at 4°C until further use.
Instrumentation
1

H NMR: Samples of each monomer (5-10 mg) or polymer (50 mg) were dissolved in

DMSO-d6 or chloroform-d (1 mL). The samples were processed in the Bruker DPX-300 MHz
spectrometer using the TOPSPIN 1.3 program for 25 scans. Polymer samples were vacuum-dried
before dissolving in the deuterated solvent.
13

C NMR: Samples of each monomer and polymer (40-50 mg) were dissolved in DMSO-d6

(1 mL). The samples were processed in the Bruker DPX-300 MHz spectrometer using the TOPSPIN
1.3 program for 1000 scans. Polymer samples were vacuum-dried before dissolving in the
deuterated solvent.
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FT-IR: Monomer or polymer samples (1- 5 mg) were placed in the PerkinElmer Spectrum
2 FT-IR spectrometer and scanned to gain their respective spectra. Polymer samples were
vacuum-dried and desiccated before analysis.
Gel Permeation Chromatography (GPC): Gel permeation chromatography (GPC) was
performed with a Waters 2410 DRI gel permeation chromatograph, consisting of four phenogel 5
μL columns filled with cross-linked polystyrene-divinylbenzene (PSDVB) beads. The polymer
samples (5 mg) were first vacuum-dried, dissolved in THF (1 mL), then transferred to a GPC vial.
The flow rate of tetrahydrofuran (THF) eluent was set to 1 mL/min at 25oC for 50 minutes.
Thermogravimetric Analysis (TGA): The thermal stability of the polymer was tested on a
TA Instruments Q50 thermogravimetric analyzer. Polymer samples of about 5 mg were weighed,
equilibrated, and then heated under nitrogen atmosphere using a heating ramp of 10°C/min for
60 minutes, ranging from 25 to 600°C.
Differential Scanning Calorimetry (DSC): The calorimetric parameters of the polymer
were gauged on a TA Instruments Q100 differential scanning calorimeter. Polymer samples of
about 7-8 mg were used for the test. The device was set to run three cycles ranging from -70°C to
160°C, with a ramp of 10°C/min. The beginning of each cycle was precluded by a three-minute
isothermal period, after which the ramping would begin again.
Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF): Analysis was
performed on the Bruker microflex™ LRF MALDI-TOF. The matrix for the samples was prepared
per protocol in the Bruker user manual. First, TA30 solvent (30:70 volume ratio of acetonitrile to
0.1% trifluoroacetic acid) was prepared in 100 µL quantity. Then 2,5-dihydroxybenzoic acid (2 mg)
was thoroughly dissolved and mixed in the TA30 to complete the matrix. Next, the polymer
sample (5 mg) was vacuum dried, desiccated, and then dissolved in methanol (100 mL). The
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polymer solution and TA30 matrix were then combined into a single Eppendorf tube and vortexed
(1000 rpm) for 2 minutes to ensure complete mixing. The resulting solution was then spotted (1
µL drop size) in the wells of a ground steel MALDI target plate. The spots were left to dry
completely (approx. 6 hours) and placed in the mass spectrometer for analysis.
Dynamic Light Scattering and Zeta Potential: The polymeric nanoparticle (10 µL) solution
was added to deionized water (1 mL). This solution was then placed in a standard cuvette for DLS
reading, or a specialized electrode-containing cuvette for zeta potential determination. The
appropriate cuvette was placed in the Malvern ZS90 zetasizer and the program set up
(approximately 50 readings in 3 cycles) for the appropriate data acquisition.
Uv/Vis and Fluorescence Analysis: UV/Vis spectra were recorded using a Tecan infinite
M200 Pro microplate reader. Samples of polymeric nanoparticle suspension (50 μL) were placed
in the wells of a 96-well plate and placed in the spectrophotometer. Absorbance scans were set
to read a range of 300-800 nm, while fluorescence emission scans were set to read wavelengths
of 600-900 nm. Readings were taken at intervals of 5 nm, with 10 flashes for each reading. The
resulting data points were transferred to Microsoft Excel and plotted to visualize and compare
the two samples.
Cell Studies
Cell Culturing: LNCaP and PC3 prostate cancer cells were grown in a specially formulated
media containing, by volume, 85% RPMI-1640 media, 10% fetal bovine serum, and 5%
Penicillin/Streptomycin antibiotic. These components were mixed, vacuum-filtered, and stored at
4°C until needed. The cells taken from cryo were re-suspended in this media (5 mL), transferred
to a 7-mL culture flask, and incubated at 37°C. Cells were split to new flasks with fresh media as
needed to prevent overcrowding and to increase the longevity of the cells. Cell samples used for
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assays were taken from flasks with the most recently changed media and at least 24 hours old, or
roughly 80% confluent.
MTT Assay: Fresh cells were cultured in a 96-well plate and incubated with 50 µL dosages
of the polymeric nanoparticle formulations (both with and without folic acid and Taxol) for 24
hours. Following the incubation, the media was removed and 50 µL of 1X PBS was added to the
cells for washing. The PBS was removed, then 25 µL of the MTT solution (50 mg MTT in 10 mL 1X
PBS) is added to the wells and incubated for 4-6 hours. After incubation, the excess MTT solution
was drained from the wells, then 30 µL of isopropanol added. The cells then were ready to be
read in the TECAN Infinite M200 PRO multi-detection microplate reader (at 560 nm absorbance)
to determine the efficacy of nanoparticle treatment.
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